SIRT3 and colorectal carcinoma: Then, we analyzed the correlation between SIRT3 immunostaining and the SUVmax in 71 patients who underwent PET/CT, and SIRT3 immunostaining was inversely correlated with the SUVmax of patients with CRC (Supplementary Figure 3J).